Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

What Happened? Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.5% in the afternoon session after Canaccord Genuity maintained its 'Buy' rating and $3.70 price target on the ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health Investments Corp (NASDAQ:CLOV) saw its shares jump more than 12.54% to $3.77 on Wednesday by market close, following better-than-expected profitability in the first quarter, despite ...

Clover Health's unique Medicare PPO plans target underserved rural populations, offering in-home services and modern technology for effective health management. Despite a leading benefit expense ratio ...

Clover Health Investments, Corp. announced that Lee A. Shapiro, a member of its Board of Directors, will not seek reelection after serving for four years due to his new role as Chairman of the ...

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in ...